Metabolic Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Rutgers New Jersey Medical School, Newark, NJ, USA.
JNCI Cancer Spectr. 2022 Nov 1;6(6). doi: 10.1093/jncics/pkac066.
Body mass index (BMI) during adulthood has been associated with pancreatic ductal adenocarcinoma (PDAC), however, patterns of body size across the adult life course have not been studied extensively. We comprehensively evaluated the association between adiposity across adulthood and PDAC.
We conducted a prospective analysis of 269 480 (162 735 males, 106 745 females) National Institutes of Health-AARP Diet and Health Study participants, aged 50-71 years (1995-1996) who self-reported height and weight history. Participants were followed through December 31, 2011. We examined associations between BMI (kg/m2) at ages 18, 35, 50, and 50-71 (baseline) years, their trajectories determined from latent-class trajectory modeling, and incident PDAC. Cox proportional hazard models were used to calculate multivariable adjusted hazards ratios (HRs) and 95% confidence intervals (CIs).
During up to 15.2 years of follow-up, 3092 (2020 males, 1072 females) patients with incident PDAC were identified. BMI at all 4 ages were statistically significantly associated with increased PDAC (per 5-unit increase, HR = 1.09-1.13) with higher magnitude associations in males than females at ages 35 years and older (Pinteraction < .05). Four BMI trajectories were created. Compared with normal-weight maintainers, normal-to-overweight, normal-to-obese class I, and overweight-to-obese class III trajectories had hazard ratios of 1.15 (95% CI = 1.06 to 1.25), 1.39 (95% CI = 1.25 to 1.54), and 1.48 (95% CI = 1.18 to 1.87), respectively (Pinteraction by sex = .07).
High BMI and BMI trajectories that result in overweight or obesity during adulthood were positively associated with PDAC, with stronger associations among those with early onset adiposity and those with male sex. Avoidance of excess body weight throughout the adult life course may prevent PDAC.
成年人的体重指数(BMI)与胰腺导管腺癌(PDAC)有关,然而,成年期的体型模式尚未得到广泛研究。我们全面评估了成年期肥胖与 PDAC 之间的关系。
我们对 269480 名(男性 162735 名,女性 106745 名)美国国立卫生研究院-美国退休人员协会饮食与健康研究参与者进行了前瞻性分析,这些参与者年龄在 50-71 岁(1995-1996 年),报告了身高和体重史。参与者随访至 2011 年 12 月 31 日。我们研究了 BMI(kg/m2)在 18、35、50 岁及 50-71 岁(基线)时的相关性,以及通过潜在类别轨迹建模确定的 BMI 轨迹与 PDAC 发病之间的相关性。Cox 比例风险模型用于计算多变量调整后的风险比(HR)和 95%置信区间(CI)。
在长达 15.2 年的随访期间,共发现 3092 名(男性 2020 名,女性 1072 名)PDAC 患者。所有 4 个年龄的 BMI 均与 PDAC 风险增加显著相关(每增加 5 个单位,HR=1.09-1.13),且男性在 35 岁及以上年龄时的相关性高于女性(P 交互作用<0.05)。创建了 4 种 BMI 轨迹。与体重正常的维持者相比,正常体重至超重、正常体重至肥胖 I 类和超重至肥胖 III 类的 HR 分别为 1.15(95%CI=1.06-1.25)、1.39(95%CI=1.25-1.54)和 1.48(95%CI=1.18-1.87)(性别交互作用 P=0.07)。
成年后 BMI 升高和导致超重或肥胖的 BMI 轨迹与 PDAC 呈正相关,在发病较早的肥胖者和男性中相关性更强。在整个成年期避免体重增加可能有助于预防 PDAC。